Students & Alumni
Inara Ali
Project Manager
UCSF Pacific Pediatric Neuro-Oncology
Shreya Beri
LSRP (Mary E. Hartnett’s lab) Stanford Ophthalmology
Purdue University, Neurobiology BS
Nixuan Cai
LSRP (Kevin Alexander Lab)
Stanford Medicine – Cardiovascular Institute
Esra Dogan
Laboratory Technician
Medical Technologist
Cornell University
Devon Gaur
VP Clinical Operations
TOCA Health
Kenneth Ho, MA
Vice President
Ori Capital, Hong Kong
Nadya Iswari
Junior Scientist
Genecis Bioindustries, Canada
Ifan Jenkin, BMBCh, MA
Fulbright Scholar
Medical Doctor, United Kingdom
Liyuan Ji, MPharmSci
Head of Formulation Chemist
Revea
Nadia Kaveh
LSRP (Melody Smith Lab)
Stanford Medicine - BMT
Anisha Laumas
LSRP (Purvesh Khatri Lab)
Stanford Medicine – Biomedical Informatics
Obioma Nwankwo
Sachs Foundation Scholar
Clinical Study Coordinator
Medtronic
Rahul Penumaka, MBBS
Knight-Hennessy Scholar
Medical Doctor, United Kingdom
Charles Racz
LSRP (Sharon Hori Lab)
Stanford Canary Center - Radiology
Elena Rubini
Investment Banking Analyst
JP Morgan, United Kingdom
News About M-TRAM Students and Alumni
Rahul Penumaka awarded the prestigious Knight-Hennessy Scholarship (KHS) to study at M-TRAM. The program is considered one of the most prestigious and competitive scholarships in the world. In 2024, 90 scholars were selected from a pool of 8,272 applicants for a selection rate of 1.09%.
Rahul Penumaka (M-TRAM 2024/25)
Massive congratulations to HLA Scholar Ifan Jenkin for receiving the Fulbright All Disciplines Postgraduate Award for a Master's of Science in Translational Research and Applied Medicine at Stanford University!
Ifan Jenkin (M-TRAM 2024/25)
Frank Lin, MS, M-TRAM Graduate '23, contributes to breakthrough cancer treatment research: his M-TRAM Capstone Project mentored by Professor Crystal Mackall culminates in high-impact Nature paper.
The study, which was a culmination of Frank's capstone research for M-TRAM, demonstrated a novel approach to cancer therapy by combining antibodies with T cells. By engineering a variant of the CD47 protein, which usually signals immune cells not to attack healthy tissue, researchers enhanced the immune system's ability to target cancer cells. This breakthrough could pave the way for more effective cancer treatments, leveraging the body's own defenses to combat tumors with greater precision and potency.
Wolf Earns M-TRAM Master’s Degree | Mahajan Laboratories
Palo Alto, CA — Julian Wolf M.D., postdoctoral fellow in the Mahajan Lab, graduated with the first class of Stanford’s Master of Science in Translational Research and Applied Medicine (M-TRAM) Program. Nobel Laureate and Stanford Professor Carolyn Bertozzi Ph.D. gave the keynote and her congratulations to Julian. The aim of the M-TRAM Program is to give graduates the tools to
'Disease accelerates aging': Stanford researchers develop an AI-driven aging clock for eyes
Using eye fluid samples from liquid biopsies, Stanford researchers created a protein-cell map connecting 6,000 eye proteins back to their cellular origins, 26 of which were incorporated into an AI model to predict a patient’s age.